Answers are grounded in this paper and cite their sources.
This revised article addresses Q0142, 'How can actinide and lanthanide separations exploit subtle covalency differences more reliably?' using a question-specific mathematical construction rather than a generic logarithmic template. The proposed model, termed the Covalency-Resolved f-Element Separation Model, uses binding free energies DeltaG_Ln, DeltaG_An, covalency descriptor C_cov and distribution ratios and is ordered along ligand identity, oxidation state and solvent. The construction is anchored to external primary research classified as DIRECT SUPPORT in the validation atlas. The external evidence establishes experimentally measurable mechanisms or target performance; it is not conflated with proof of the new equation itself. The model defines explicit state variables, derives a dimensionless objective or hazard, specifies a prospective calibration procedure, and states falsifiable predictions. The experimental constraint carried forward from the atlas is: Covalency/ligand-field differences can be exploited in actinide/lanthanide separations, but broad reliability across feeds is not complete. The article incorporates the required correction: Use element-specific covalency descriptors and competing-ion terms.
No takes yet. Share an insight, caveat, or question.
Begüm Yıldırım (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: